Technical improvements in head and neck cancer radiotherapy over the last decade have resulted in substantial reductions in dose to organs-at-risk. For a mix of tumors, we saw less xerostomia moving from 3D-conformal to more advanced techniques. For oropharynx-only there were additional improvements, including in global quality-of-life and sticky saliva.
Keywords: Head and neck radiotherapy; Organ at risk sparing; Patient reported outcome; Quality of life.
Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.